期刊文献+

静脉滴注氟康唑致精神异常 被引量:4

Mental disorders attributed to an IV infusion of fluconazole
原文传递
导出
摘要 1例87岁男性患者,因慢性阻塞性肺疾病(COPD)急性发作和白色念珠菌感染,静脉滴注氟康唑0.4 g,1次/d。当晚出现兴奋、烦躁、乱语、双手颤抖等症状。第3天将氟康唑剂量降至0.2 g,1次/d,同时给予抗精神病药物,但患者的精神症状仍进行性加重。第5天停用氟康唑,改为口服伊曲康唑胶囊,患者精神症状消失。第8、10天痰培养结果均为阴性,COPD症状缓解。出院后15 d电话随访,患者未再出现精神异常。 An 87 year-old male patient received an IV infusion of fluconazole 0. dg once daily for chronic obstructive pulmonary disease (COPD) and Candida albicans infection. The patient experienced agitation, anxiety, delirium, and trembling of his hands at the night. On day 3, the dose of fluconazole reduced to 0.2 g once daily, and a antipsychotic medication was given. But the patient' s mental symptoms was progressively exacerbated. On the day 5, flueonazole was discontinued, and itraconazole capsules were given orally. The patient's mental symptoms disappeared. On days 8 and 10, sputum cultures results were negative, and the symptoms of COPD was relieved. The patient's mental symptoms did not reappear on telephone follow-up at 15 days after discharge.
出处 《药物不良反应杂志》 2012年第5期323-324,共2页 Adverse Drug Reactions Journal
关键词 氟康唑 精神异常 fluconazole mental disorder
  • 相关文献

参考文献7

  • 1陈新谦;金有豫;汤光.新编药物学[M]北京:人民卫生出版社,2011117-118.
  • 2张金萍,陈超.氟康唑预防极低出生体重儿真菌感染有效性和安全性的Meta分析[J].中华儿科杂志,2009,47(12):891-897. 被引量:17
  • 3Wang JL,Chang CH,Young-Xu Y. Systematic review and meta-analysis of the tolerability and hepatotoxicity of antifungals in empirical and definitive therapy for invasive fungal infection[J].Antimicrobial Agents and Chemotherapy,2010,(06):2409-2419.doi:10.1128/AAC.01657-09.
  • 4赵志刚;潘华.氟康唑引起精神症状一例报告[J]中国临床药理学杂志,1995(01):19.
  • 5谢志进,王彦川,王涛,孙伟,何阳君.氟康唑致精神障碍[J].药物不良反应杂志,2009,11(5):361-361. 被引量:8
  • 6Aronson JK.MEYLER药物副作用-国际药物不良反应和相互作用百科全书[M]北京:科学出版社,20091379.
  • 7匡培根.药物引起的神经精神不良反应[M]北京:人民卫生出版社,2001179-182.

二级参考文献31

  • 1卫生部合理用药专家委员会.中国医师药师临床用药指南[M].重庆出版社,2009:229.
  • 2赵志刚 潘华.氟康唑引起精神症状一例报告.中国临床药理学杂志,1995,(1):19-19.
  • 3Stoll B J, Gordon T, Korones SB, et al. Late-onset sepsis in very low birth weight neonates: a report from the National Institute of Child Health and Human Development Neonatal Research Network. J Pediatr, 1996 ,129(1) :63-71.
  • 4Chapman RL, Faix RG. Invasive neonatal candidiasis: overview. Semin Perinatol, 2003,27:352-356.
  • 5Lee, BE, Cheung PY, Robinson JL, et al. Comparative study of mortality and morbidity in premature infants (birth weight, < 1250 g) with candidemia or candidal meningitis. Clin Infect Dis, 1998,27:559-565.
  • 6Kicklighter SD, Springer SC, Cox T, et al. Fluconazole for prophylaxis against candidal rectal colonization in the very low birth weight infant. Pediatrics, 2001, 107:293-298.
  • 7Manzoni P, Arisio R, Mostert M, et al. Prophylactic fluconazole is effective in preventing fungal colonization and fungal systemic infections in preterm neonates : a single-center, 6-year, retrospective cohort study. Pediatrics, 2006,117 ( 1 ) : e22-32.
  • 8McCrossan BA, McHenry E, O'Neill F, et al. Selective fluconazole prophylaxis in high-risk babies to reduce invasive fungal infection. Arch Dis Child Fetal Neonatal Ed, 2007,92: F454-458.
  • 9Dutta S, Murki S, Varma S, et al. Effects of cessation of a policy of neonatal fluconazole prophylaxis on fungal resurgence. Indian Pediatr, 2005,42 : 1226-1230.
  • 10Kaufman D, Boyle R, Hazen KC, et al. Fluconazole prophylaxis against fungal colonization and infection in preterm infants. N Engl J Med, 2001, 345:1660-1666.

共引文献23

同被引文献26

引证文献4

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部